ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79 | -32.5% | 24,801 | +5.4% | 0.00% | 0.0% |
| Q2 2023 | $117 | -11.4% | 23,521 | -11.8% | 0.00% | 0.0% |
| Q1 2023 | $132 | -18.5% | 26,655 | +3.4% | 0.00% | 0.0% |
| Q4 2022 | $162 | -99.9% | 25,790 | -8.3% | 0.00% | -50.0% |
| Q3 2022 | $304,000 | +112.6% | 28,115 | +123.6% | 0.00% | +100.0% |
| Q2 2022 | $143,000 | -2.1% | 12,572 | -21.5% | 0.00% | 0.0% |
| Q1 2022 | $146,000 | -34.2% | 16,022 | +7.5% | 0.00% | 0.0% |
| Q4 2021 | $222,000 | -30.6% | 14,898 | +19.6% | 0.00% | -50.0% |
| Q3 2021 | $320,000 | +56.9% | 12,460 | +59.4% | 0.00% | +100.0% |
| Q2 2021 | $204,000 | -12.1% | 7,815 | +18.8% | 0.00% | 0.0% |
| Q1 2021 | $232,000 | -72.4% | 6,580 | -70.5% | 0.00% | -80.0% |
| Q3 2020 | $840,000 | – | 22,284 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
| Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
| TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
| Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
| Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
| Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
| HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
| Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
| Navalign, LLC | 64,428 | $961,000 | 0.38% |
| Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |